July 17, 2017

CVS Health president and CEO Larry Merlo made the announcement alongside Rhode Island Gov. Gina Raimondo at the 2017 National Governor’s Association Summer Meeting, where Merlo has been touting the company’s approach to providing accessible and effective care.

July 14, 2017

Tremfya (guselkumab) is the first drug to be approved that selectively blocks a key plaque psoriasis cytokine, the company said.

July 14, 2017

Mike Hotra joins the organization as VP of its public affairs team, and Ken McKay is the advocacy organization’s new VP state government affairs. 

July 10, 2017

Endari (L-glutamine oral powder) was developed and is manufactured by Emmaus Life Sciences.

July 10, 2017

The program would restore access to chain and independent pharmacies for TRICARE beneficiaries, who currently have to obtain non-generic medications through mail-order pharmacies or military treatment facilities.

July 5, 2017

Advent International is buying the Mexican private generics leader from Endo for roughly $124 million. 

June 30, 2017

Along with the new indication, the Food and Drug Administration DA approved a next-generation sequencing-based test to identify the RAS mutation status of a patient’s tumor, which Amgen said helps identify patients who would benefit from treatment with Vectibix. 

June 29, 2017

The agency has outlined its Orphan Drug Modernization plan, which it said is part of a larger effort called the Medical Innovation Development plan modernize and make efficient the FDA’s regulatory tools and policies.

June 28, 2017

Patients with diabetes who create an account on the Blink Health website or mobile app will be able to receive a year’s supply of metformin, glipizide and pioglitazone for free. 

June 23, 2017

The company has looked to the president and CEO of its Purdue Pharma Canada to lead the U.S. business.

June 22, 2017

According to the CDC, American adults are behind on routine annual vaccinations.

June 20, 2017

The company said that it’s expecting a launch in the second-half of 2017, and that it has already submitted an application to the FDA for a junior version of Symjepi.

June 15, 2017

CVS Health’s April survey found that 88% of respondents are somewhat or very concerned about the high cost of prescription drugs.

June 13, 2017

The award recognizes character and professional accomplishments, as well as leadership in HDA, the industry and the community.

June 2, 2017

The National Association of Chain Drug Stores and the American Pharmacists Association shared their concerns with the Trump Administration about the potential impact of drug importation on patient safety and the delivery of value-based care. 

June 1, 2017

The InspiraChamber is designed to minimize the time it takes to administer asthma medications, Lupin said.

June 1, 2017

Since 2011, 68 novel therapies have been approved globally across 22 cancer indications. The QunitilesIMS Institute report looks at what technological advances and development trends have made this possible, as well as their cost.

May 31, 2017

The study found that vaccinated adults were 52%-79% less likely to die than unvaccinated flu-hospitalized patients.

May 24, 2017

Government agency accepted Biologics License Application to extend Opdivo’s use to patients with hepatocellular carcinoma after prior sorafenib therapy.

May 23, 2017

According to the agency, this is the first time it has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.

May 22, 2017

Hoffman La Roche’s drug takes aim at the form of vasculitis, a group of disorders that results in inflammation of blood vessels.

May 19, 2017

The oral therapy is administered twice daily for adults with an FLT3 mutation-positive acute myeloid leukemia diagnosis.

May 17, 2017

The Natural Products Association on Tuesday expressed support of the reorganization of the Office of Regulatory Affairs by FDA.

May 17, 2017

According to the FDA, the expanded approval of Kalydeco triples the number of rare gene mutations that the drug can now treat, expanding the indication from the treatment of 10 mutations, to 33.